Ceramide-orchestrated signalling in cancer cells (original) (raw)

• Levy, M. & Futerman, A. H. Mammalian ceramide synthases. IUBMB Life 62, 347–356 (2010).
  CAS PubMed Central PubMed Google Scholar
• Tettamanti, G., Bassi, R., Viani, P. & Riboni, L. Salvage pathways in glycosphingolipid metabolism. Biochimie 85, 423–437 (2003).
  CAS PubMed Google Scholar
• Kitatani, K., Idkowiak-Baldys, J. & Hannun, Y. A. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell. Signal. 20, 1010–1018 (2008).
  CAS PubMed Google Scholar
• Mullen, T. D., Hannun, Y. A. & Obeid, L. M. Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem. J. 441, 789–802 (2012).
  CAS PubMed Google Scholar
• Senchenkov, A., Litvak, D. A. & Cabot, M. C. Targeting ceramide metabolism-a strategy for overcoming drug resistance. J. Natl Cancer Inst. 93, 347–357 (2001).
  CAS PubMed Google Scholar
• Kolesnick, R. & Fuks, Z. Radiation and ceramide-induced apoptosis. Oncogene 22, 5897–5906 (2003).
  CAS PubMed Google Scholar
• Truman, J. P. et al. Down-regulation of ATM protein sensitizes human prostate cancer cells to radiation-induced apoptosis. J. Biol. Chem. 280, 23262–23272 (2005).
  CAS PubMed Google Scholar
• Hannun, Y. A. & Obeid, L. M. Many ceramides. J. Biol. Chem. 286, 27855–27862 (2011).
  CAS PubMed Central PubMed Google Scholar
• Tidhar, R. et al. Acyl chain specificity of ceramide synthases is determined within a region of 150 residues in the Tram-Lag-CLN8 (TLC) domain. J. Biol. Chem. 287, 3197–3206 (2012).
  CAS PubMed Google Scholar
• Grosch, S., Schiffmann, S. & Geisslinger, G. Chain length-specific properties of ceramides. Prog. Lipid Res. 51, 50–62 (2012).
  PubMed Google Scholar
• Siddique, M. M. et al. Ablation of dihydroceramide desaturase confers resistance to Etoposide-induced apoptosis in vitro. PLoS ONE 7, e44042 (2012). This work defines the importance of the 4,5- trans double bond in cell survival and sensitivity to anticancer agents, and thus exemplifies intricate points of ceramide molecular species specificity.
  CAS PubMed Central PubMed Google Scholar
• Liu, Y. Y. et al. Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-α-induced apoptosis. Exp. Cell Res. 252, 464–470 (1999). This paper describes for the first time the therapeutic impact of targeting GCS to confer resistance to TNF.
  CAS PubMed Google Scholar
• Bleicher, R. J. & Cabot, M. C. Glucosylceramide synthase and apoptosis. Biochim. Biophys. Acta 1585, 172–178 (2002).
  CAS PubMed Google Scholar
• Meng, A. et al. Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells. Exp. Cell Res. 292, 385–392 (2004).
  CAS PubMed Google Scholar
• Mitra, P. et al. Ceramide kinase regulates growth and survival of A549 human lung adenocarcinoma cells. FEBS Lett. 581, 735–740 (2007). This paper shows that CERK controls the balance between pro-apoptotic ceramide and anti-apoptotic ceramide 1-phosphate to regulate the growth and survival of cancer cells.
  CAS PubMed Google Scholar
• Kolesnick, R. N. & Hemer, M. R. Characterization of a ceramide kinase activity from human leukemia (HL-60) cells. Separation from diacylglycerol kinase activity. J. Biol. Chem. 265, 18803–18808 (1990). This paper is the first record of CERK activity distinct from diacylglycerol kinase activity, as shown in a leukaemia cell model.
  CAS PubMed Google Scholar
• Gomez-Munoz, A. Ceramide 1-phosphate/ceramide, a switch between life and death. Biochim. Biophys. Acta 1758, 2049–2056 (2006).
  CAS PubMed Google Scholar
• Bornancin, F. Ceramide kinase: the first decade. Cell. Signal. 23, 999–1008 (2011).
  CAS PubMed Google Scholar
• Wang, H. et al. N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing. Mol. Cancer Ther. 7, 2967–2976 (2008).
  CAS PubMed Google Scholar
• Sun, W. et al. Alkaline ceramidase 2 regulates β1 integrin maturation and cell adhesion. FASEB J. 23, 656–666 (2009).
  CAS PubMed Central PubMed Google Scholar
• Pyne, N. J. & Pyne, S. Sphingosine 1-phosphate and cancer. Nature Rev. Cancer 10, 489–503 (2010).
  CAS Google Scholar
• Liu, X. et al. Acid ceramidase inhibition: a novel target for cancer therapy. Front. Biosci. 13, 2293–2298 (2008).
  CAS PubMed Google Scholar
• Liu, X. et al. Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy. Expert Opin. Ther. Targets 13, 1449–1458 (2009).
  CAS PubMed Central PubMed Google Scholar
• Flowers, M. et al. C6-Ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth. Breast Cancer Res. Treat. 133, 447–458 (2011).
  PubMed Google Scholar
• Gouaze-Andersson, V. et al. Inhibition of acid ceramidase by a 2-substituted aminoethanol amide synergistically sensitizes prostate cancer cells to N-(4-hydroxyphenyl) retinamide. Prostate 71, 1064–1073 (2011).
  CAS PubMed Google Scholar
• Morad, S. A. et al. Ceramide-antiestrogen nanoliposomal combinations - novel impact of hormonal therapy in hormone-insensitive breast cancer. Mol Cancer Ther 11, 2352–2361 (2012).
  CAS PubMed Central PubMed Google Scholar
• Gatt, S. Enzymic Hydrolysis and Synthesis of Ceramides. J. Biol. Chem. 238, 3131–3133 (1963).
  CAS PubMed Google Scholar
• Baran, Y. et al. Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. J. Biol. Chem. 282, 10922–10934 (2007).
  CAS PubMed Google Scholar
• Canals, D., Perry, D. M., Jenkins, R. W. & Hannun, Y. A. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases. Br. J. Pharmacol. 163, 694–712 (2011).
  CAS PubMed Central PubMed Google Scholar
• Kolesnick, R., Altieri, D. & Fuks, Z. A. CERTain role for ceramide in taxane-induced cell death. Cancer Cell 11, 473–475 (2007).
  CAS PubMed Google Scholar
• Charles, A. G. et al. Taxol-induced ceramide generation and apoptosis in human breast cancer cells. Cancer Chemother. Pharmacol. 47, 444–450 (2001).
  CAS PubMed Google Scholar
• Zeidan, Y. H., Jenkins, R. W. & Hannun, Y. A. Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway. J. Cell Biol. 181, 335–350 (2008).
  CAS PubMed Central PubMed Google Scholar
• Rothstein, T. L. Inducible resistance to Fas-mediated apoptosis in B cells. Cell Res. 10, 245–266 (2000).
  CAS PubMed Google Scholar
• Thorburn, A., Behbakht, K. & Ford, H. TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them. Drug Resist. Updat. 11, 17–24 (2008).
  CAS PubMed Central PubMed Google Scholar
• Zhang, L. & Fang, B. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Cancer Gene Ther. 12, 228–237 (2005).
  CAS PubMed Google Scholar
• Park, M. A. et al. Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca2+ -de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathway. Cancer Res. 70, 6313–6324 (2010).
  CAS PubMed Central PubMed Google Scholar
• Park, M. A. et al. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biol. Ther. 7, 1648–1662 (2008).
  CAS PubMed Google Scholar
• Huang, S. T., Yang, R. C., Chen, M. Y. & Pang, J. H. Phyllanthus urinaria induces the Fas receptor/ligand expression and ceramide-mediated apoptosis in HL-60 cells. Life Sci. 75, 339–351 (2004).
  CAS PubMed Google Scholar
• Dumitru, C. A. & Gulbins, E. TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis. Oncogene 25, 5612–5625 (2006). This paper demonstrates that TRAIL activates acid sphingomyelinase via a mechanism involving reactive oxygen species that results in release of ceramide and formation of ceramide-enriched membrane platforms.
  CAS PubMed Google Scholar
• Miyaji, M. et al. Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis. J. Exp. Med. 202, 249–259 (2005). This paper reported that membrane sphingomyelin is important for FAS clustering through aggregation of ceramide-enriched membrane platforms, leading to FAS-mediated apoptosis.
  CAS PubMed Central PubMed Google Scholar
• Grassme, H. et al. CD95 signaling via ceramide-rich membrane rafts. J. Biol. Chem. 276, 20589–20596 (2001). This paper shows that CD95-mediated clustering by ceramide is a prerequisite for signalling and cell death.
  CAS PubMed Google Scholar
• Stancevic, B. & Kolesnick, R. Ceramide-rich platforms in transmembrane signaling. FEBS Lett. 584, 1728–1740 (2010).
  CAS PubMed Central PubMed Google Scholar
• Cremesti, A. et al. Ceramide enables fas to cap and kill. J. Biol. Chem. 276, 23954–23961 (2001).
  CAS PubMed Google Scholar
• Dumitru, C. A., Carpinteiro, A., Trarbach, T., Hengge, U. R. & Gulbins, E. Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms. Apoptosis 12, 1533–1541 (2007).
  CAS PubMed Google Scholar
• Min, Y. et al. Death receptor 5-recruited raft components contributes to the sensitivity of Jurkat leukemia cell lines to TRAIL-induced cell death. IUBMB Life 61, 261–267 (2009).
  CAS PubMed Google Scholar
• Grassme, H., Schwarz, H. & Gulbins, E. Molecular mechanisms of ceramide-mediated CD95 clustering. Biochem. Biophys. Res. Commun. 284, 1016–1030 (2001).
  CAS PubMed Google Scholar
• Grassme, H., Cremesti, A., Kolesnick, R. & Gulbins, E. Ceramide-mediated clustering is required for CD95-DISC formation. Oncogene 22, 5457–5470 (2003).
  CAS PubMed Google Scholar
• Schaefer, J. T., Barthlen, W. & Schweizer, P. Ceramide induces apoptosis in neuroblastoma cell cultures resistant to CD95 (Fas/APO-1)-mediated apoptosis. J. Pediatr. Surg. 35, 473–479 (2000).
  CAS PubMed Google Scholar
• Herr, I., Wilhelm, D., Bohler, T., Angel, P. & Debatin, K. M. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16, 6200–6208 (1997).
  CAS PubMed Central PubMed Google Scholar
• Wagenknecht, B., Roth, W., Gulbins, E., Wolburg, H. & Weller, M. C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis. Cell Death Differ. 8, 595–602 (2001).
  CAS PubMed Google Scholar
• Zhang, Y., Yoshida, T. & Zhang, B. TRAIL induces endocytosis of its death receptors in MDA-MB-231 breast cancer cells. Cancer Biol. Ther. 8, 917–922 (2009).
  CAS PubMed Google Scholar
• White-Gilbertson, S. et al. Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 28, 1132–1141 (2009). This paper reports the potential of modulation of CERS6 as a therapeutic strategy to alter apoptotic susceptibility.
  CAS PubMed Central PubMed Google Scholar
• Voelkel-Johnson, C., Hannun, Y. A. & El-Zawahry, A. Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein. Mol. Cancer Ther. 4, 1320–1327 (2005).
  CAS PubMed Google Scholar
• Asakuma, J., Sumitomo, M., Asano, T. & Hayakawa, M. Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel. Cancer Res. 63, 1365–1370 (2003).
  CAS PubMed Google Scholar
• Colell, A., Morales, A., Fernandez-Checa, J. C. & Garcia-Ruiz, C. Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-α-mediated apoptosis in human colon HT-29 cells through glycosphingolipids formation. Possible role of ganglioside GD3. FEBS Lett. 526, 135–141 (2002).
  CAS PubMed Google Scholar
• Cai, Z. et al. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-α-mediated cytotoxicity. J. Biol. Chem. 272, 6918–6926 (1997).
  CAS PubMed Google Scholar
• Autelli, R. et al. Divergent pathways for TNF and C2-ceramide toxicity in HTC hepatoma cells. Biochim. Biophys. Acta 1793, 1182–1190 (2009).
  CAS PubMed Google Scholar
• Higuchi, M., Singh, S., Jaffrezou, J. P. & Aggarwal, B. B. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-κ B activation. J. Immunol. 157, 297–304 (1996).
  CAS PubMed Google Scholar
• Kuroki, J. et al. Cell-permeable ceramide inhibits the growth of B lymphoma Raji cells lacking TNF-α-receptors by inducing G0/G1 arrest but not apoptosis: a new model for dissecting cell-cycle arrest and apoptosis. Leukemia 10, 1950–1958 (1996).
  CAS PubMed Google Scholar
• Lamour, N. F. et al. Ceramide kinase regulates the production of tumor necrosis factor α (TNFα) via inhibition of TNFα-converting enzyme. J. Biol. Chem. 286, 42808–42817 (2011).
  CAS PubMed Central PubMed Google Scholar
• Donato, N. J. & Klostergaard, J. Distinct stress and cell destruction pathways are engaged by TNF and ceramide during apoptosis of MCF-7 cells. Exp. Cell Res. 294, 523–533 (2004).
  CAS PubMed Google Scholar
• Guo, Y. L., Kang, B., Yang, L. J. & Williamson, J. R. Tumor necrosis factor-α and ceramide induce cell death through different mechanisms in rat mesangial cells. Am. J. Physiol. 276, F390–F397 (1999).
  CAS PubMed Google Scholar
• Karasavvas, N. & Zakeri, Z. Relationships of apoptotic signaling mediated by ceramide and TNF-α in U937 cells. Cell Death Differ. 6, 115–123 (1999).
  CAS PubMed Google Scholar
• Kimura, K., Markowski, M., Edsall, L. C., Spiegel, S. & Gelmann, E. P. Role of ceramide in mediating apoptosis of irradiated LNCaP prostate cancer cells. Cell Death Differ. 10, 240–248 (2003).
  CAS PubMed Google Scholar
• Goswami, R., Kilkus, J., Scurlock, B. & Dawson, G. CrmA protects against apoptosis and ceramide formation in PC12 cells. Neurochem. Res. 27, 735–741 (2002).
  CAS PubMed Google Scholar
• De Nadai, C. et al. Nitric oxide inhibits tumor necrosis factor-α-induced apoptosis by reducing the generation of ceramide. Proc. Natl Acad. Sci. USA 97, 5480–5485 (2000).
  CAS PubMed PubMed Central Google Scholar
• Sawada, M. et al. Molecular mechanisms of TNF-α-induced ceramide formation in human glioma cells: P53-mediated oxidant stress-dependent and -independent pathways. Cell Death Differ. 11, 997–1008 (2004).
  CAS PubMed Google Scholar
• Yoon, G. et al. Ceramide increases Fas-mediated apoptosis in glioblastoma cells through FLIP down-regulation. J. Neurooncol 60, 135–141 (2002).
  PubMed Google Scholar
• Nam, S. Y., Amoscato, A. A. & Lee, Y. J. Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway. Oncogene 21, 337–346 (2002).
  CAS PubMed Google Scholar
• Rippo, M. R. et al. FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells. Oncogene 23, 7753–7760 (2004).
  CAS PubMed Google Scholar
• Zhou, X. D. et al. Overexpression of cellular FLICE-inhibitory protein (FLIP) in gastric adenocarcinoma. Clin. Sci. 106, 397–405 (2004).
  CAS Google Scholar
• Babiychuk, E. B. et al. The targeting of plasmalemmal ceramide to mitochondria during apoptosis. PLoS ONE 6, e23706 (2011). This paper describes how plasmalemmal ceramide reaches mitochondria and induces apoptosis.
  CAS PubMed Central PubMed Google Scholar
• Babiychuk, E. B., Monastyrskaya, K. & Draeger, A. Fluorescent annexin A1 reveals dynamics of ceramide platforms in living cells. Traffic 9, 1757–1775 (2008).
  CAS PubMed Google Scholar
• Stiban, J., Caputo, L. & Colombini, M. Ceramide synthesis in the endoplasmic reticulum can permeabilize mitochondria to proapoptotic proteins. J. Lipid Res. 49, 625–634 (2008). This paper reports the link between ceramide synthesis in the ER and ceramide-mitochondrial apoptosis.
  CAS PubMed Google Scholar
• Bionda, C., Portoukalian, J., Schmitt, D., Rodriguez-Lafrasse, C. & Ardail, D. Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria? Biochem. J. 382, 527–533 (2004).
  CAS PubMed Central PubMed Google Scholar
• Novgorodov, S. A. et al. Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide from sphingosine and acyl-CoA. J. Biol. Chem. 286, 25352–25362 (2011). This paper reports a novel pathway of ceramide production in mitochondria.
  CAS PubMed Central PubMed Google Scholar
• Wu, B. X., Rajagopalan, V., Roddy, P. L., Clarke, C. J. & Hannun, Y. A. Identification and characterization of murine mitochondria-associated neutral sphingomyelinase (MA-nSMase), the mammalian sphingomyelin phosphodiesterase 5. J. Biol. Chem. 285, 17993–18002 (2010).
  CAS PubMed Central PubMed Google Scholar
• Birbes, H., El Bawab, S., Hannun, Y. A. & Obeid, L. M. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J. 15, 2669–2679 (2001).
  CAS PubMed Google Scholar
• Siskind, L. J., Kolesnick, R. N. & Colombini, M. Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins. J. Biol. Chem. 277, 26796–26803 (2002).
  CAS PubMed Google Scholar
• Siskind, L. J., Kolesnick, R. N. & Colombini, M. Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations. Mitochondrion 6, 118–125 (2006).
  CAS PubMed Central PubMed Google Scholar
• Siskind, L. J. & Colombini, M. The lipids C2− and C16-ceramide form large stable channels. Implications for apoptosis. J. Biol. Chem. 275, 38640–38644 (2000). This paper is the first report of stable pore formation by a lipid in a membrane.
  CAS PubMed Google Scholar
• Ganesan, V. et al. Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane. Apoptosis 15, 553–562 (2010). This paper reports the role of both ceramide and BCL-2 family proteins in permeabilization of the outer mitochondrial membrane.
  CAS PubMed Google Scholar
• von Haefen, C. et al. Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. Oncogene 21, 4009–4019 (2002). This paper reports that BAX is a key activator of ceramide-mediated cancer cell death pathways.
  CAS PubMed Google Scholar
• Lee, H. et al. Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation. PLoS ONE 6, e19783 (2011).
  CAS PubMed Central PubMed Google Scholar
• Martinez-Abundis, E., Correa, F., Pavon, N. & Zazueta, C. Bax distribution into mitochondrial detergent-resistant microdomains is related to ceramide and cholesterol content in postischemic hearts. FEBS J. 276, 5579–5588 (2009).
  CAS PubMed Google Scholar
• Belaud-Rotureau, M. A. et al. Early transitory rise in intracellular pH leads to Bax conformation change during ceramide-induced apoptosis. Apoptosis 5, 551–560 (2000).
  CAS PubMed Google Scholar
• Tsuruta, F. et al. JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J. 23, 1889–1899 (2004). This paper reveals a key role of BAX in the regulation of stress-induced apoptosis.
  CAS PubMed Central PubMed Google Scholar
• Yoshida, K., Yamaguchi, T., Natsume, T., Kufe, D. & Miki, Y. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage. Nature Cell Biol. 7, 278–285 (2005).
  CAS PubMed Google Scholar
• Kong, J. Y., Klassen, S. S. & Rabkin, S. W. Ceramide activates a mitochondrial p38 mitogen-activated protein kinase: a potential mechanism for loss of mitochondrial transmembrane potential and apoptosis. Mol. Cell Biochem. 278, 39–51 (2005).
  CAS PubMed Google Scholar
• Kim, H. J., Oh, J. E., Kim, S. W., Chun, Y. J. & Kim, M. Y. Ceramide induces p38 MAPK-dependent apoptosis and Bax translocation via inhibition of Akt in HL-60 cells. Cancer Lett. 260, 88–95 (2008). This paper demonstrates that ceramide-induced p38 MAPK activation negatively regulates the AKT pathway.
  CAS PubMed Google Scholar
• Lin, C. F. et al. GSK-3β acts downstream of PP2A and the PI 3-kinase-Akt pathway, and upstream of caspase-2 in ceramide-induced mitochondrial apoptosis. J. Cell Sci. 120, 2935–2943 (2007). This paper reports a role for GSK3β in ceramide-induced mitochondrial apoptosis.
  CAS PubMed Google Scholar
• Sanvicens, N. & Cotter, T. G. Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells. J. Neurochem. 98, 1432–1444 (2006).
  CAS PubMed Google Scholar
• De Stefanis, D. et al. Increase in ceramide level alters the lysosomal targeting of cathepsin D prior to onset of apoptosis in HT-29 colon cancer cells. Biol. Chem. 383, 989–999 (2002).
  CAS PubMed Google Scholar
• Heinrich, M. et al. Ceramide as an activator lipid of cathepsin D. Adv. Exp. Med. Biol. 477, 305–315 (2000).
  CAS PubMed Google Scholar
• Heinrich, M. et al. Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 18, 5252–5263 (1999).
  CAS PubMed Central PubMed Google Scholar
• Darios, F., Lambeng, N., Troadec, J. D., Michel, P. P. & Ruberg, M. Ceramide increases mitochondrial free calcium levels via caspase 8 and Bid: role in initiation of cell death. J. Neurochem. 84, 643–654 (2003).
  CAS PubMed Google Scholar
• Yuan, H., Williams, S. D., Adachi, S., Oltersdorf, T. & Gottlieb, R. A. Cytochrome c dissociation and release from mitochondria by truncated Bid and ceramide. Mitochondrion 2, 237–244 (2003).
  CAS PubMed Google Scholar
• Lin, C. F. et al. Bcl-2 rescues ceramide- and etoposide-induced mitochondrial apoptosis through blockage of caspase-2 activation. J. Biol. Chem. 280, 23758–23765 (2005).
  CAS PubMed Google Scholar
• Sumitomo, M. et al. Protein kinase Cδ amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. J. Clin. Invest. 109, 827–836 (2002).
  CAS PubMed Central PubMed Google Scholar
• Pinton, P. et al. The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J. 20, 2690–2701 (2001).
  CAS PubMed Central PubMed Google Scholar
• Raisova, M. et al. Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release. FEBS Lett. 473, 27–32 (2000).
  CAS PubMed Google Scholar
• Morales, M. C. et al. 4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bcl-2. Free Radic. Res. 41, 591–601 (2007).
  CAS PubMed Google Scholar
• Hockenbery, D. M. Targeting mitochondria for cancer therapy. Environ. Mol. Mutagen. 51, 476–489 (2010).
  CAS PubMed Google Scholar
• Johnstone, R. W., Ruefli, A. A. & Lowe, S. W. Apoptosis: a link between cancer genetics and chemotherapy. Cell 108, 153–164 (2002).
  CAS PubMed Google Scholar
• Kang, M. H. & Reynolds, C. P. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin. Cancer Res. 15, 1126–1132 (2009).
  CAS PubMed Central PubMed Google Scholar
• Yu, T., Li, J., Qiu, Y. & Sun, H. 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation. Mol. Cell. Biochem. 361, 47–54 (2012).
  CAS PubMed Google Scholar
• Jiang, Y. et al. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biol. Ther. 12, 574–585 (2011).
  CAS PubMed Central PubMed Google Scholar
• Zhu, Q. Y. et al. C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and α-tubulin hyperacetylation both in vitro and in vivo. Cell Death Dis. 2, e117 (2011).
  PubMed Central PubMed Google Scholar
• Tagaram, H. R. et al. Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma. Gut 60, 695–701 (2011). This paper shows that nanoliposomal ceramide is an efficacious antineoplastic agent in an in vivo model of human hepatocellular carcinoma.
  CAS PubMed Google Scholar
• Kim, S. W., Kim, H. J., Chun, Y. J. & Kim, M. Y. Ceramide produces apoptosis through induction of p27(kip1) by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells. J. Toxicol. Environ. Health A 73, 1465–1476 (2010).
  CAS PubMed Google Scholar
• Blouin, C. M. et al. Plasma membrane subdomain compartmentalization contributes to distinct mechanisms of ceramide action on insulin signaling. Diabetes 59, 600–610 (2010).
  CAS PubMed Google Scholar
• Bourbon, N. A., Yun, J. & Kester, M. Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex. J. Biol. Chem. 275, 35617–35623 (2000).
  CAS PubMed Google Scholar
• Powell, D. J., Hajduch, E., Kular, G. & Hundal, H. S. Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCzeta-dependent mechanism. Mol. Cell. Biol. 23, 7794–7808 (2003).
  CAS PubMed Central PubMed Google Scholar
• Bourbon, N. A., Sandirasegarane, L. & Kester, M. Ceramide-induced inhibition of Akt is mediated through protein kinase Czeta: implications for growth arrest. J. Biol. Chem. 277, 3286–3292 (2002). This paper demonstrates that ceramide downregulates AKT through PKCζ.
  CAS PubMed Google Scholar
• Fox, T. E. et al. Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. J. Biol. Chem. 282, 12450–12457 (2007). This paper demonstrates that structured membrane microdomains are necessary for ceramide-induced activation of PKCζ and resultant diminished AKT activity.
  CAS PubMed Google Scholar
• Dobrowsky, R. T., Kamibayashi, C., Mumby, M. C. & Hannun, Y. A. Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268, 15523–15530 (1993). This paper is the first demonstration that ceramide activation of heterotrimeric PP2A requires the presence of a B subunit.
  CAS PubMed Google Scholar
• Mukhopadhyay, A. et al. Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling. FASEB J. 23, 751–763 (2009). This paper shows that regulation of PP2A signalling involves direct interaction between ceramide and inhibitor 2.
  CAS PubMed Central PubMed Google Scholar
• Kuo, Y. C. et al. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55α regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J. Biol. Chem. 283, 1882–1892 (2008).
  CAS PubMed Google Scholar
• Ugi, S. et al. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol. Cell. Biol. 24, 8778–8789 (2004).
  CAS PubMed Central PubMed Google Scholar
• Zhang, Q. J. et al. Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes 61, 1848–1859 (2012).
  CAS PubMed Central PubMed Google Scholar
• Chen, C. L. et al. Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood 111, 4365–4374 (2008). This paper reports that TXNIP is involved in ceramide-induced p38 MAPK and JNK phosphorylation and cell death.
  CAS PubMed Google Scholar
• Messner, M. C. & Cabot, M. C. Cytotoxic responses to N-(4-hydroxyphenyl)retinamide in human pancreatic cancer cells. Cancer Chemother. Pharmacol. 68, 477–487 (2011).
  CAS PubMed Google Scholar
• Mondal, S., Mandal, C., Sangwan, R. & Chandra, S. Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. Mol. Cancer 9, 239 (2010).
  PubMed Central PubMed Google Scholar
• Hilchie, A. L. et al. Curcumin-induced apoptosis in PC3 prostate carcinoma cells is caspase-independent and involves cellular ceramide accumulation and damage to mitochondria. Nutr. Cancer 62, 379–389 (2010).
  CAS PubMed Google Scholar
• Maziere, C. et al. UVA radiation stimulates ceramide production: relationship to oxidative stress and potential role in ERK, JNK, and p38 activation. Biochem. Biophys. Res. Commun. 281, 289–294 (2001).
  CAS PubMed Google Scholar
• Sanchez, A. M. et al. Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accumulation, neutral sphingomyelinase, and JNK activation. Apoptosis 12, 2013–2024 (2007).
  CAS PubMed Google Scholar
• Takeda, K. et al. Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1. J. Biol. Chem. 282, 7522–7531 (2007).
  CAS PubMed Google Scholar
• Pruschy, M. et al. Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells. Br. J. Cancer 80, 693–698 (1999).
  CAS PubMed Central PubMed Google Scholar
• Kim, S. S. et al. P53 mediates ceramide-induced apoptosis in SKN-SH cells. Oncogene 21, 2020–2028 (2002).
  CAS PubMed Google Scholar
• Deng, X., Gao, F. & May, W. S. Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding. Blood 113, 422–428 (2009).
  CAS PubMed Central PubMed Google Scholar
• Temme, A. et al. Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax. Cancer Lett. 250, 177–193 (2007).
  CAS PubMed Google Scholar
• Blanc-Brude, O. P. et al. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin. Cancer Res. 9, 2683–2692 (2003).
  CAS PubMed Google Scholar
• Mesri, M. et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am. J. Pathol. 158, 1757–1765 (2001).
  CAS PubMed Central PubMed Google Scholar
• Liu, X. et al. Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia. Blood 116, 4192–4201 (2010). This paper reports the therapeutic impact of nanoliposomal ceramide in NK-LGL leukaemia and the role of survivin downregulation.
  CAS PubMed Central PubMed Google Scholar
• McKenzie, J. A., Liu, T., Goodson, A. G. & Grossman, D. Survivin enhances motility of melanoma cells by supporting Akt activation and α5 integrin upregulation. Cancer Res. 70, 7927–7937 (2010).
  CAS PubMed Central PubMed Google Scholar
• Shaner, R. L. et al. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J. Lipid Res. 50, 1692–1707 (2009).
  CAS PubMed Central PubMed Google Scholar
• Scarlatti, F. et al. Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1. J. Biol. Chem. 279, 18384–18391 (2004). This paper describes the pivotal role of AKT1in ceramide-induced autophagy.
  CAS PubMed Google Scholar
• Pattingre, S., Bauvy, C., Levade, T., Levine, B. & Codogno, P. Ceramide-induced autophagy: to junk or to protect cells? Autophagy 5, 558–560 (2009).
  CAS PubMed Google Scholar
• Guenther, G. G. et al. Ceramide starves cells to death by downregulating nutrient transporter proteins. Proc. Natl Acad. Sci. USA 105, 17402–17407 (2008).
  CAS PubMed PubMed Central Google Scholar
• Pozuelo-Rubio, M. Regulation of autophagic activity by 14-3-3zeta proteins associated with class III phosphatidylinositol-3-kinase. Cell Death Differ. 18, 479–492 (2011). This paper reports that 14-3-3ζ is a negative regulator of ceramide-induced autophagy through the regulation of a key component of early stages of the autophagy pathway.
  CAS PubMed Google Scholar
• Venable, M. E., Bielawska, A. & Obeid, L. M. Ceramide inhibits phospholipase D in a cell-free system. J. Biol. Chem. 271, 24800–24805 (1996).
  CAS PubMed Google Scholar
• Daido, S. et al. Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res. 64, 4286–4293 (2004). This paper reports that ceramide induces autophagy via activation of BNIP3.
  CAS PubMed Google Scholar
• Mammucari, C. et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 6, 458–471 (2007).
  CAS PubMed Google Scholar
• Nath, K. A. The role of Sirt1 in renal rejuvenation and resistance to stress. J. Clin. Invest. 120, 1026–1028 (2010).
  CAS PubMed Central PubMed Google Scholar
• Peralta, E. R. & Edinger, A. L. Ceramide-induced starvation triggers homeostatic autophagy. Autophagy 5, 407–409 (2009).
  CAS PubMed Google Scholar
• Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biol. 13, 132–141 (2011).
  CAS PubMed Google Scholar
• Sun, T. et al. c-Jun NH2-terminal kinase activation is essential for up-regulation of LC3 during ceramide-induced autophagy in human nasopharyngeal carcinoma cells. J. Transl. Med. 9, 161 (2011). This paper shows that the transcription factor JUN is involved in LC3 transcriptional regulation in response to ceramide.
  CAS PubMed Central PubMed Google Scholar
• Pattingre, S. et al. Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy. J. Biol. Chem. 284, 2719–2728 (2009). This paper describes the potential role of JNK1 activation in ceramide-induced autophagy.
  CAS PubMed Central PubMed Google Scholar
• Li, D. D. et al. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene 28, 886–898 (2009).
  CAS PubMed Google Scholar
• Park, M. A. et al. Regulation of autophagy by ceramide-CD95-PERK signaling. Autophagy 4, 929–931 (2008). This paper reports ceramide–CD95–PERK signalling as a novel pathway involved in autophagy.
  CAS PubMed Google Scholar
• Spassieva, S. D., Mullen, T. D., Townsend, D. M. & Obeid, L. M. Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response. Biochem. J. 424, 273–283 (2009). This paper reports a novel role of CERS2 in the induction of autophagy.
  CAS PubMed Google Scholar
• Tanabe, F., Cui, S. H. & Ito, M. Ceramide promotes calpain-mediated proteolysis of protein kinase C β in murine polymorphonuclear leukocytes. Biochem. Biophys. Res. Commun. 242, 129–133 (1998).
  CAS PubMed Google Scholar
• Xie, H. & Johnson, G. V. Ceramide selectively decreases tau levels in differentiated PC12 cells through modulation of calpain I. J. Neurochem. 69, 1020–1030 (1997).
  CAS PubMed Google Scholar
• Demarchi, F., Bertoli, C., Greer, P. A. & Schneider, C. Ceramide triggers an NF-κB-dependent survival pathway through calpain. Cell Death Differ. 12, 512–522 (2005).
  CAS PubMed Google Scholar
• Demarchi, F. et al. Calpain is required for macroautophagy in mammalian cells. J. Cell Biol. 175, 595–605 (2006).
  CAS PubMed Central PubMed Google Scholar
• Lepine, S., Allegood, J. C., Edmonds, Y., Milstien, S. & Spiegel, S. Autophagy induced by deficiency of sphingosine-1-phosphate phosphohydrolase 1 is switched to apoptosis by calpain-mediated autophagy-related gene 5 (Atg5) cleavage. J. Biol. Chem. 286, 44380–44390 (2011).
  CAS PubMed Central PubMed Google Scholar
• Walker, T. et al. Sorafenib and vorinostat kill colon cancer cells by CD95-dependent and -independent mechanisms. Mol. Pharmacol. 76, 342–355 (2009).
  CAS PubMed Central PubMed Google Scholar
• Zheng, W. et al. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim. Biophys. Acta 1758, 1864–1884 (2006).
  CAS PubMed Google Scholar
• Wang, H., Maurer, B. J., Reynolds, C. P. & Cabot, M. C. N-(4-hydroxyphenyl)retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase. Cancer Res. 61, 5102–5105 (2001).
  CAS PubMed Google Scholar
• Rahmaniyan, M. et al. Identification of dihydroceramide desaturase as a direct in vitro target for fenretinide. J. Biol. Chem. 286, 24754–24764 (2011).
  CAS PubMed Central PubMed Google Scholar
• Maurer, B. J., Metelitsa, L. S., Seeger, R. C., Cabot, M. C. & Reynolds, C. P. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines. J. Natl Cancer Inst. 91, 1138–1146 (1999).
  CAS PubMed Google Scholar
• Fazi, B. et al. Fenretinide induces autophagic cell death in caspase-defective breast cancer cells. Autophagy 4, 435–441 (2008).
  CAS PubMed Google Scholar
• Liu, X. W. et al. HIF-1α-dependent autophagy protects HeLa cells from fenretinide (4-HPR)-induced apoptosis in hypoxia. Pharmacol. Res. 62, 416–425 (2010).
  PubMed Google Scholar
• Signorelli, P. et al. Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells. Cancer Lett. 282, 238–243 (2009).
  CAS PubMed Google Scholar
• Jiang, Q. et al. γ-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide. Int. J. Cancer 130, 685–693 (2012).
  CAS PubMed Google Scholar
• Kroemer, G. & Jaattela, M. Lysosomes and autophagy in cell death control. Nature Rev. Cancer 5, 886–897 (2005).
  CAS Google Scholar
• Separovic, D. et al. Increased ceramide accumulation correlates with downregulation of the autophagy protein ATG-7 in MCF-7 cells sensitized to photodamage. Arch. Biochem. Biophys. 494, 101–105 (2010).
  CAS PubMed Google Scholar
• Bhutia, S. K. et al. Autophagy switches to apoptosis in prostate cancer cells infected with melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24). Autophagy 7, 1076–1077 (2011).
  CAS PubMed Central PubMed Google Scholar
• Turner, L. S. et al. Autophagy is increased in prostate cancer cells overexpressing acid ceramidase and enhances resistance to C6 ceramide. Prostate Cancer Prostat. Dis. 14, 30–37 (2011).
  CAS Google Scholar
• Fujiwara, K. et al. Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy. J. Biol. Chem. 283, 388–397 (2008).
  CAS PubMed Google Scholar
• Young, M. M. et al. Autophagosomal membrane serves as platform for intracellular death-inducing signaling complex (iDISC)-mediated caspase-8 activation and apoptosis. J. Biol. Chem. 287, 12455–12468 (2012).
  CAS PubMed Central PubMed Google Scholar
• Mirzoeva, O. K. et al. Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K-mTOR pathway in pancreatic adenocarcinoma. J. Mol. Med. 89, 877–889 (2011).
  CAS PubMed Google Scholar
• Thomas, S., Thurn, K. T., Bicaku, E., Marchion, D. C. & Munster, P. N. Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy. Breast Cancer Res. Treat. 130, 437–447 (2011).
  CAS PubMed Central PubMed Google Scholar
• Han, W. et al. Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells. PLoS ONE 6, e28491 (2011).
  CAS PubMed Central PubMed Google Scholar
• Struckhoff, A. P., Patel, B. & Beckman, B. S. Inhibition of p53 sensitizes MCF-7 cells to ceramide treatment. Int. J. Oncol. 37, 21–30 (2010).
  CAS PubMed Google Scholar
• Wang, J., Lv, X. W., Shi, J. P. & Hu, X. S. Mechanisms involved in ceramide-induced cell cycle arrest in human hepatocarcinoma cells. World J. Gastroenterol. 13, 1129–1134 (2007). This paper reports the importance of PPARγ activation in ceramide-induced cell cycle arrest.
  CAS PubMed Central PubMed Google Scholar
• Lee, J. Y., Bielawska, A. E. & Obeid, L. M. Regulation of cyclin-dependent kinase 2 activity by ceramide. Exp. Cell Res. 261, 303–311 (2000). This paper revealed that ceramide regulates CDK2 through p21 and protein phosphatases to induce cell cycle arrest.
  CAS PubMed Google Scholar
• Kim, W. H., Kang, K. H., Kim, M. Y. & Choi, K. H. Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells. Biochem. Cell Biol. 78, 127–135 (2000).
  CAS PubMed Google Scholar
• Alesse, E. et al. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering. Cell Death Differ. 5, 381–389 (1998).
  CAS PubMed Google Scholar
• Han, C. et al. PPARγ ligands inhibit cholangiocarcinoma cell growth through p53-dependent GADD45 and p21 pathway. Hepatology 38, 167–177 (2003).
  PubMed Google Scholar
• Kraveka, J. M. et al. Involvement of dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells. J. Biol. Chem. 282, 16718–16728 (2007).
  CAS PubMed Google Scholar
• Clarke, C. J. et al. Neutral sphingomyelinase-2 mediates growth arrest by retinoic acid through modulation of ribosomal S6 kinase. J. Biol. Chem. 286, 21565–21576 (2011).
  CAS PubMed Central PubMed Google Scholar
• Zhu, X. F., Liu, Z. C., Xie, B. F., Feng, G. K. & Zeng, Y. X. Ceramide induces cell cycle arrest and upregulates p27kip in nasopharyngeal carcinoma cells. Cancer Lett. 193, 149–154 (2003).
  CAS PubMed Google Scholar
• Phillips, D. C. et al. Ceramide-induced G2 arrest in rhabdomyosarcoma (RMS) cells requires p21Cip1/Waf1 induction and is prevented by MDM2 overexpression. Cell Death Differ. 14, 1780–1791 (2007).
  CAS PubMed Google Scholar
• Lechler, P. et al. The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro. BMC Cancer 11, 120 (2011).
  CAS PubMed Central PubMed Google Scholar
• Ahn, E. H. & Schroeder, J. J. Induction of apoptosis by sphingosine, sphinganine, and C2-ceramide in human colon cancer cells, but not by C2-dihydroceramide. Anticancer Res. 30, 2881–2884 (2010).
  CAS PubMed Google Scholar
• Tsaur, I. et al. The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line. Cancer Lett. 313, 84–90 (2011).
  CAS PubMed Google Scholar
• Scaltriti, M. et al. Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+ breast cancer patients. Proc. Natl Acad. Sci. USA 108, 3761–3766 (2011).
  CAS PubMed Central PubMed Google Scholar
• Zwart, W. et al. Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1. Mol. Endocrinol. 23, 1335–1345 (2009).
  CAS PubMed Central PubMed Google Scholar
• Obama, K., Kanai, M., Kawai, Y., Fukushima, M. & Takabayashi, A. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells. Int. J. Oncol. 21, 309–314 (2002).
  CAS PubMed Google Scholar
• Kolesnick, R. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J. Clin. Invest. 110, 3–8 (2002).
  CAS PubMed Central PubMed Google Scholar
• Ogretmen, B. & Hannun, Y. A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nature Rev. Cancer 4, 604–616 (2004).
  CAS Google Scholar
• Barth, B. M., Cabot, M. C. & Kester, M. Ceramide-based therapeutics for the treatment of cancer. Anticancer Agents Med. Chem. 11, 911–919 (2011).
  CAS PubMed Google Scholar
• Haimovitz-Friedman, A. et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 180, 525–535 (1994).
  CAS PubMed Google Scholar
• Santana, P. et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86, 189–199 (1996).
  CAS PubMed Google Scholar
• Silva, L. C. et al. Ablation of ceramide synthase 2 strongly affects biophysical properties of membranes. J. Lipid Res. 53, 430–436 (2012).
  CAS PubMed Central PubMed Google Scholar
• Pewzner-Jung, Y. et al. A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy. J. Biol. Chem. 285, 10911–10923 (2010).
  CAS PubMed Central PubMed Google Scholar
• Kohno, M. et al. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol. Cell. Biol. 26, 7211–7223 (2006).
  CAS PubMed Central PubMed Google Scholar
• Kawamori, T. et al. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 23, 405–414 (2009).
  CAS PubMed Central PubMed Google Scholar
• Kummar, S. et al. Phase I trial of fenretinide lym-x-sorb oral powder in adults with solid tumors and lymphomas. Anticancer Res. 31, 961–966 (2011).
  CAS PubMed PubMed Central Google Scholar
• Villablanca, J. G. et al. Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group. Clin. Cancer Res. 17, 6858–6866 (2011).
  CAS PubMed Central PubMed Google Scholar
• Tran, M. A., Smith, C. D., Kester, M. & Robertson, G. P. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development. Clin. Cancer Res. 14, 3571–3581 (2008).
  CAS PubMed Google Scholar
• Stover, T. C., Sharma, A., Robertson, G. P. & Kester, M. Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma. Clin. Cancer Res. 11, 3465–3474 (2005).
  CAS PubMed Google Scholar
• Morad, S. A. F. et al. Tamoxifen enhances chemotherapeutic efficacy of C6− ceramide and increases induction of apoptosis in human colorectal cancer cells by upregulation of MAPK signaling pathway and down-regulation of inhibitor of apoptosis protein, survivin. FASEB J. 26, 993.1 (2012).
  Google Scholar
• Kornhuber, J. et al. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell. Physiol. Biochem. 26, 9–20 (2010).
  CAS PubMed Google Scholar
• Smith, E. L. & Schuchman, E. H. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J. 22, 3419–3431 (2008).
  CAS PubMed Central PubMed Google Scholar
• Ling, L. U., Lin, H., Tan, K. B. & Chiu, G. N. The role of protein kinase C in the synergistic interaction of safingol and irinotecan in colon cancer cells. Int. J. Oncol. 35, 1463–1471 (2009).
  CAS PubMed Google Scholar
• Ling, L. U., Tan, K. B. & Chiu, G. N. Role of reactive oxygen species in the synergistic cytotoxicity of safingol-based combination regimens with conventional chemotherapeutics. Oncol. Lett. 2, 905–910 (2011).
  CAS PubMed Central PubMed Google Scholar
• Coward, J. et al. Safingol (L-threo-sphinganine) induces autophagy in solid tumor cells through inhibition of PKC and the PI3-kinase pathway. Autophagy 5, 184–193 (2009).
  CAS PubMed Google Scholar
• Dickson, M. A. et al. A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. Clin. Cancer Res. 17, 2484–2492 (2011).
  CAS PubMed Central PubMed Google Scholar